numer
virus
abl
caus
respiratori
tract
infect
avail
new
molecular
techniqu
number
pathogen
detect
specimen
human
respiratori
tract
increas
viral
infect
potenti
lead
sever
system
diseas
virus
limit
play
role
pathogenesi
common
cold
syndrom
chapter
focus
viral
pathogen
link
common
cold
intent
comprehens
review
virus
abl
caus
respiratori
tract
infect
would
go
beyond
scope
book
list
virus
briefli
review
includ
rhinovirus
respiratori
syncyti
viru
parainfluenza
viru
adenoviru
metapneumoviru
coronaviru
bocaviru
discuss
one
exampl
newli
identifi
pathogen
less
establish
role
etiolog
pathogenesi
common
cold
numer
virus
abl
caus
respiratori
tract
infect
may
also
caus
sever
diseas
other
limit
role
pathogenesi
common
cold
syndrom
avail
new
molecular
techniqu
number
pathogen
detect
specimen
human
respiratori
tract
increas
associ
agent
human
respiratori
diseas
alway
clear
intent
chapter
comprehens
review
virolog
virus
caus
potenti
caus
respiratori
tract
infect
chapter
focus
pathogen
link
common
cold
list
virus
describ
includ
rhinoviru
respiratori
syncyti
viru
parainfluenza
viru
adenoviru
metapneumoviru
coronaviru
bocaviru
discuss
exampl
newli
identifi
pathogen
less
establish
role
etiolog
pathogenesi
common
cold
influenza
viru
caus
defin
common
cold
associ
respiratori
diseas
clinic
pictur
mild
influenza
frequent
overlap
common
cold
therefor
influenza
virus
briefli
describ
chapter
detail
biolog
individu
virus
role
pathogenesi
respiratori
diseas
read
standard
literatur
text
book
virolog
recommend
virus
establish
role
common
cold
rhinovirus
adenovirus
parainfluenza
virus
coronavirus
respiratori
syncyti
viru
review
greater
detail
structur
replic
transmiss
epidemiolog
clinic
symptom
describ
addit
brief
comment
current
model
pathogenesi
anim
model
respect
complet
respect
subchapt
tabl
provid
overview
virus
caus
respiratori
tract
infect
may
play
role
caus
pathogenesi
common
cold
number
virus
frequent
codetect
virus
human
respiratori
diseas
therefor
viral
etiolog
role
virus
pathogenesi
common
cold
complex
safe
say
fulli
understood
everi
viru
link
respiratori
tract
infect
recent
develop
field
antivir
describ
chapter
tom
jefferson
book
rhinovirus
caus
vast
major
common
cold
human
although
infect
usual
self
limit
symptom
diseas
mild
healthi
adult
rhinoviru
infect
may
caus
seriou
ill
children
patient
preexist
medic
problem
taxonomi
structur
replic
rhinovirus
serotyp
strain
isol
rv
isol
human
two
human
rv
speci
describ
human
rhinoviru
hrv
b
eighteen
serotyp
subtyp
hrv
belong
hrv
five
serotyp
assign
hrv
b
serotyp
yet
assign
speci
includ
bovin
rhinovirus
brv
rv
nonenvelop
virus
icosahedr
symmetri
viru
small
diamet
approxim
nm
four
capsid
protein
describ
protom
compos
one
copi
precursor
coval
link
cleavag
final
step
assembl
process
one
two
copi
remain
uncleav
role
uncleav
establish
yet
five
protom
arrang
symmetr
fivefold
axi
form
pentam
repres
corner
icosahedron
capsid
form
pentam
rv
similar
human
enterovirus
compar
uneven
surfac
characterist
canyon
around
fivefold
axi
canyon
serv
attach
site
cell
receptor
cscl
rv
buoyant
densiti
g
cm
virion
unstabl
ph
featur
distinguish
rv
enterovirus
howev
nonenvelop
virus
rv
stabl
deterg
organ
solvent
hand
alcohol
phenol
effect
virucid
agent
rv
genom
organ
singlestrand
positivesens
rna
approxim
nucleotid
length
terminu
coval
link
small
protein
vpg
region
utr
approxim
kb
shorter
enterovirus
owe
delet
approxim
nucleotid
intern
ribosom
entri
site
ire
translat
start
site
one
open
read
frame
orf
codon
approxim
nucleotid
poli
tail
complet
structur
genom
rv
characterist
nucleotid
composit
preponder
u
particularli
third
posit
codon
genom
fulli
sequenc
access
number
replic
initi
attach
cell
receptor
rv
serotyp
intercellular
adhes
hypothes
viral
canyon
structur
releas
lipid
moieti
upon
bind
turn
lead
chang
conform
destabil
releas
viral
rna
cytoplasm
rv
shut
host
cell
protein
synthesi
inactiv
cap
bind
complex
ire
allow
replic
despit
inactiv
rna
serv
messeng
rna
encod
singl
polyprotein
cleav
posttransl
virusencod
proteas
first
round
translat
subsequ
process
complet
pol
rnadepend
rna
polymeras
produc
negativesens
rna
genom
templat
turn
serv
templat
product
positivesens
genom
rna
synthesi
singl
viru
polyprotein
requir
posttransl
process
facilit
subsequ
step
viral
replic
least
two
proteolyt
activ
encod
viru
pro
perform
first
cleavag
releas
capsid
precursor
pro
catalyz
cleavag
reaction
proteas
trypsinlik
structur
activ
site
enzym
cystein
sulfydryl
rv
transmit
mainli
direct
contact
less
frequent
aerosol
detail
see
chapter
dian
pappa
owen
hendley
viru
frequent
isol
hand
infect
individu
transmit
individu
object
environ
rv
infect
viru
titer
nasal
secret
high
tcid
ml
nasal
lavag
fluid
infect
human
effect
less
rv
may
need
infect
seroneg
volunt
nasal
drop
need
infect
human
embryon
fibroblast
tissu
cultur
contrast
viru
use
inhal
aerosol
dispar
infecti
dose
describ
suggest
lower
respiratori
tract
less
suscept
infect
nasopharynx
short
incub
period
day
viru
shed
peak
anoth
day
declin
thereaft
primari
site
viral
replic
ciliat
epitheli
cell
detect
situ
hybrid
histopatholog
rv
infect
yet
detail
nasal
mucosa
biopsi
reveal
histopatholog
abnorm
despit
activ
viru
shed
explant
cultur
inocul
rhinoviru
fail
develop
cytopath
effect
cpe
biopsi
show
mark
edema
connect
tissu
spars
infiltr
inflammatori
cell
hyperemia
exud
seromuc
fluid
infect
bovin
tracheal
organ
cultur
brv
lead
shed
ciliat
cell
suggest
immun
respons
host
contribut
symptom
complex
increas
concentr
proinflammatori
cytokin
found
nasal
secret
subject
symptomat
rv
infect
direct
correl
concentr
nasal
fluid
symptom
sever
describ
rv
infect
usual
accompani
typic
common
cold
symptom
nasal
discharg
obstruct
sneez
cough
sore
throat
less
frequent
fever
gastrointestin
symptom
sometim
observ
children
infect
usual
limit
upper
respiratori
tract
commonli
believ
rv
infect
increas
risk
subsequ
secondari
bacteri
infect
patient
predispos
exist
underli
diseas
like
cystic
fibrosi
chronic
bronchiti
immunocompromis
patient
elderli
infant
rv
caus
seriou
infect
lower
respiratori
tract
rv
infect
lower
respiratori
tract
lrti
demonstr
papadopoulo
cowork
use
situ
hybrid
techniqu
author
demonstr
rv
infect
epitheli
cell
also
underli
submucos
cell
exacerb
chronic
bronchiti
asthma
may
consequ
patient
inde
approxim
asthma
exacerb
children
adult
associ
respiratori
viru
infect
vast
major
rv
infect
examin
earli
innat
immun
respons
rv
infect
asthmat
bronchial
epithelia
reveal
profound
impair
virusinduc
interferon
ifn
express
lead
impair
apoptot
respons
enhanc
rv
replic
rv
infect
lead
product
typespecif
iga
igg
igm
antibodi
howev
frequenc
respons
natur
infect
report
vari
infect
patient
usual
develop
neutral
antibodi
infect
viru
within
week
infect
iga
domin
immunoglobulin
nasal
secret
protect
role
may
prevent
reinfect
homotyp
virus
reduc
symptom
upon
reinfect
involv
viral
clearanc
process
less
clear
mechan
like
induct
innat
immun
respons
discuss
serum
secretori
antibodi
persist
sever
year
infect
absenc
effect
antivir
treatment
diagnosi
rv
infect
guid
antirv
therapi
use
diagnosi
rv
infect
larg
reli
clinic
symptom
approxim
patient
common
cold
syndrom
afebril
promin
nasal
symptom
minim
system
diseas
occur
august
earli
novemb
rv
infect
howev
gener
method
identifi
etiolog
agent
isol
propag
cell
cultur
addit
polymeras
chain
reaction
pcr
use
rapid
identif
rv
specimen
pointofcar
diagnost
develop
major
obstacl
understand
diseas
pathogenesi
lack
smallanim
model
rv
infect
rv
shown
high
degre
speci
specif
limit
use
experiment
anim
system
therefor
aspect
pathogenesi
studi
experiment
induc
cold
human
volunt
infect
rabbit
guinea
pig
weanl
mice
parenter
rout
success
certain
strain
viru
infect
mice
possibl
use
tissuecultur
adapt
chimpanze
gibbon
experiment
infect
use
specif
strain
hrv
approxim
rv
use
human
cell
receptor
bind
mous
remain
use
member
lowdens
lipoprotein
receptor
famili
bind
mous
counterpart
recent
three
novel
mous
model
rv
infect
minorgroup
rv
infect
balbc
mice
majorgroup
rv
infect
transgen
balbc
mice
express
mousehuman
chimera
rvinduc
exacerb
allerg
airway
inflamm
describ
bartlett
et
al
model
featur
similar
observ
rv
infect
human
includ
augment
allerg
airway
inflamm
may
use
develop
futur
therapi
cold
asthma
exacerb
associ
common
cold
symptom
inflammatori
mediat
import
aspect
understand
common
cold
rv
infect
although
associ
seem
obviou
exact
mechan
less
clear
one
might
expect
better
understand
detail
mechan
inhibitor
viral
replic
avail
studi
human
addit
new
anim
model
develop
bartlett
et
al
expect
support
effort
studi
pathogenesi
rv
infect
vivo
greater
detail
human
respiratori
syncyti
viru
rsv
first
isol
laboratori
chimpanze
upper
respiratori
tract
infect
urti
rsv
today
recogn
lead
viral
agent
upper
respiratori
tract
diseas
infanc
childhood
spectrum
rsvcaus
diseas
includ
rhiniti
otiti
media
pneumonia
bronchiol
latter
two
diseas
associ
substanti
morbid
mortal
addit
grow
recognit
import
caus
agent
diseas
elderli
immunocompromis
patient
world
health
organ
estim
rsv
caus
million
infect
death
annual
bovin
rsv
brsv
describ
caus
econom
import
respiratori
diseas
cattl
anoth
anim
rsv
pneumonia
viru
mice
pvm
suggest
interspeci
spread
evolut
virus
howev
anim
reservoir
human
rsv
describ
far
despit
import
rsv
lead
caus
respiratori
diseas
pathogenesi
rsv
infect
fulli
understood
efficaci
vaccin
avail
rsv
member
order
mononegaviral
includ
sever
nonseg
negativestrand
rna
virus
rsv
member
famili
paramyxovirida
subfamili
pneumovirina
repres
type
speci
genu
pneumoviru
rsv
virion
consist
envelop
nucleocapsid
viral
gene
express
nucleic
acid
replic
occur
cytoplasm
envelop
acquir
cell
bud
virion
spheric
pleomorph
filament
form
common
measur
nm
diamet
nm
length
surfac
virion
cover
project
spike
form
fusion
f
glycoprotein
spike
nm
long
space
nm
apart
mediat
attach
penetr
helic
nucleocapsid
filament
length
nm
width
nm
nucleocapsid
enter
cell
surfac
fusion
typic
paramyxovirus
rather
membran
fusion
may
involv
clathrinmedi
endocytosi
unseg
genom
contain
singl
molecul
linear
negativesens
singlestrand
rna
virion
occasion
contain
positivesens
singlestrand
copi
genom
partial
selfann
extract
rna
may
occur
complet
genom
approxim
nucleotid
long
fulli
sequenc
genom
access
number
rna
genom
leader
region
follow
ten
viral
gene
trailer
region
gene
transcrib
separ
mrna
encod
singl
viral
protein
except
mrna
contain
two
overlap
orf
express
ribosom
stoprestart
mechan
two
protein
although
gene
express
consist
member
order
mononegaviral
regulatori
featur
uniqu
rsv
five
nucleocapsidassoci
protein
n
nucleocapsid
protein
phosphoprotein
p
cofactor
rna
synthesi
l
protein
larg
acid
subunit
viral
polymeras
transcript
process
factor
protein
possess
regulatori
function
n
protein
bind
genom
antigenom
positivesens
intermedi
rna
protect
degrad
addit
reduc
detect
respons
host
immun
system
instanc
tolllik
receptor
tlr
intracellular
rna
recognit
helicas
initi
innat
immun
respons
viral
envelop
form
four
rsv
protein
associ
lipid
bilay
matrix
protein
locat
inner
surfac
import
assembl
virion
glycosyl
g
protein
fusion
f
protein
small
hydrophob
sh
protein
two
rsv
protein
protein
minor
part
virion
thought
modul
host
respons
rsv
infect
g
glycoprotein
kda
peptid
backbon
side
chain
import
viral
attach
host
cell
second
secretori
form
g
protein
exist
aris
second
initi
codon
g
orf
proteolyt
trim
remov
addit
amino
acid
final
protein
lack
ntermin
residu
includ
membran
anchor
ectodomain
g
protein
mucinlik
structur
differ
attach
protein
paramyxoviru
function
clear
thought
contribut
viru
spread
prevent
trap
mucu
f
protein
two
distinct
function
penetr
host
cell
membran
fusion
syncytiaform
properti
f
protein
matur
activ
furinlik
intracellular
proteas
cleav
precursor
f
three
fragment
f
f
f
f
link
disulfid
bond
repres
activ
form
f
hydrophob
n
terminu
f
conserv
within
rsv
thought
domain
insert
host
cell
membran
fusion
occur
thought
modul
host
immun
respons
rsv
lack
result
reduc
express
thought
downregul
hostdefens
antagonist
may
help
facilit
persist
rsv
infect
infect
occur
direct
contact
larg
respiratori
droplet
lesser
extent
small
droplet
site
first
replic
nasopharynx
incub
period
day
viru
spread
lower
respiratori
tract
clinic
sign
includ
cough
rhiniti
fever
sign
bronchiol
like
air
trap
wheez
increas
airway
resist
promin
clinic
symptom
cough
rhinorrhea
occur
approxim
primari
rsv
infect
infant
lesser
extent
reinfect
adult
fever
occur
infect
infant
adult
otiti
media
report
approxim
infect
infant
ear
sinu
pain
report
infect
adult
symptom
lrti
includ
bronchiol
pneumonia
croup
wheez
tracheobronch
observ
infect
infant
lesser
extent
adult
wheez
tracheobronch
promin
diseas
symptom
hospit
necessari
approxim
infect
children
infect
adult
rsv
singl
import
agent
children
younger
year
age
importantli
children
mild
rsv
diseas
also
report
recurr
wheez
year
primari
acut
diseas
extrapulmonari
dissemin
may
occur
immunocompromis
patient
viru
may
spread
kidney
liver
central
nervou
system
heart
viru
isol
nasopharynx
children
day
immunocompromis
patient
viru
recoveri
possibl
month
even
longer
immunocompet
individu
viral
infect
usual
restrict
superfici
cell
epithelia
viral
spread
outsid
respiratori
tract
uncommon
except
howev
middl
ear
viru
frequent
caus
otiti
media
typic
patholog
find
rsvinfect
tissu
includ
epitheli
necrosi
infiltr
monocyt
cell
neutrophil
airway
appear
obstruct
due
slough
cell
mucu
secret
prolifer
bronchoalveolar
epithelium
cellular
infiltr
format
syncytia
bronchoalveolar
epithelium
sometim
observ
howev
giant
cell
pneumonia
syncytia
format
relat
sever
celldefici
patient
specif
host
factor
may
influenc
clinic
sign
outcom
rsv
infect
includ
gener
health
statu
nutrit
statu
gender
ethnic
group
level
matern
antibodi
age
first
rsv
infect
underli
cardiac
pulmonari
diseas
addit
sever
environment
factor
eg
tobacco
use
household
stress
day
care
may
influenc
cours
diseas
sever
symptom
role
inflamm
bia
host
immun
respons
toward
humor
respons
typic
cytokin
discuss
controversi
literatur
strong
inflammatori
respons
seem
determin
sever
clinic
symptom
find
support
fact
mani
clinic
studi
patient
receiv
antiinflammatori
therapi
significantli
benefit
treatment
howev
strong
inflammatori
respons
also
suggest
enhanc
sever
clinic
symptom
rsv
diseas
role
inflammatori
chemokin
rsv
pathogenesi
support
mani
preclin
clinic
studi
review
exampl
genet
polymorph
increas
major
chemoattract
neutrophil
express
associ
increas
rsv
diseas
link
increas
ratio
immun
respons
bia
toward
humor
vs
classic
cytotox
respons
suggest
sever
author
discuss
base
evid
elev
respons
ratio
clinic
studi
role
key
cytokin
pathogenesi
asthma
experi
formalininactiv
rsv
vaccin
vaccin
poorli
protect
vaccin
children
infant
develop
dramat
enhanc
diseas
compar
naiv
patient
upon
natur
rsv
reinfect
subsequ
preclin
studi
confirm
bia
toward
cell
respons
anim
treat
formalininactiv
rsv
vaccin
vs
natur
infect
anim
support
isotyp
switch
ige
bound
mast
cell
eosinophil
upon
antigen
contact
induc
releas
inflammatori
mediat
like
histamin
leukotrien
cell
mediat
contribut
develop
typic
clinic
symptom
associ
rsv
diseas
sever
viral
protein
play
import
role
pathogenesi
rsv
diseas
review
solubl
g
protein
suggest
modul
innat
immun
respons
downregul
inflammatori
mediat
epitheli
cell
respons
rsv
infect
g
protein
also
modul
inflammatori
respons
monocyt
act
gener
antagonist
tlr
activ
gmediat
suppress
signal
appear
counteract
f
protein
describ
induc
signal
tlr
although
signific
activ
unclear
importantli
rsv
infect
block
matur
dendrit
cell
dc
serv
major
antigenpres
cell
review
alter
dc
biolog
may
support
shift
balanc
toward
reduc
antivir
interferon
activ
limit
mobil
matur
antigenpres
cell
thu
qualit
alter
immun
respons
rsv
infect
review
summari
sever
host
factor
viral
factor
play
role
pathogenesi
rsv
infect
pictur
howev
highli
complex
rel
contribut
variou
factor
rsv
pathogenesi
entir
understood
mention
rsv
lead
caus
respiratori
diseas
children
increas
import
caus
agent
respiratori
diseas
elderli
prospect
studi
infant
children
unit
state
rsv
detect
pediatr
hospit
bronchiol
pneumonia
bronchiti
croup
approxim
infant
infect
least
year
age
although
rsv
repres
one
serotyp
protect
immun
rsv
gener
weak
reinfect
occur
virusneutr
antibodi
includ
secretori
iga
found
respiratori
tract
contribut
viral
clearanc
may
play
role
protect
reinfect
howev
iga
respons
short
lower
respiratori
tract
igg
respons
describ
effici
role
antibodi
downmodul
clinic
symptom
confirm
clinic
experi
palivizumab
temper
region
rsv
circul
quickli
winterearli
spring
time
vari
elsewher
effect
vaccin
avail
effect
therapi
avail
howev
rsvneutral
human
monoclon
antibodi
palivizumab
reduc
rsvassoci
hospit
use
passiv
immunoprophylaxi
rsv
infect
assum
frequent
misdiagnos
particularli
adult
symptom
similar
caus
respiratori
virus
like
influenza
laboratori
diagnost
test
usual
perform
secret
sampl
obtain
nasopharynx
novel
rapid
elisabas
rtpcrbase
test
use
particularli
hospit
set
identifi
outbreak
prevent
transmiss
initi
therapi
reduc
inappropri
use
antibiot
anim
model
comprehens
review
moor
stoke
peebl
rsv
speci
specif
howev
anim
speci
exhibit
semipermiss
infect
rsv
chimpanze
product
infect
rsv
exhibit
upper
respiratori
tract
ill
wherea
adult
squirrel
monkey
newborn
rhesu
monkey
infant
cebu
monkey
show
symptom
shed
low
level
viru
bonnet
monkey
wide
avail
chimpanze
infect
rsv
nonhuman
primat
model
rsv
infect
especi
chimpanze
advantag
certainli
limit
associ
high
cost
genet
variabl
limit
reproduc
result
cotton
rat
suscept
urti
lrti
rsv
seen
one
best
anim
model
rsv
infect
diseas
anim
rsv
infect
led
histolog
confirm
prolif
rhiniti
bronchiol
pulmonari
infiltr
lymphocyt
neutrophil
cotton
rat
model
use
studi
mechan
antibodymedi
clearanc
rsv
advantag
mous
model
obviou
inexpens
inbr
strain
avail
wealth
reagent
eg
antibodi
array
probe
inform
eg
genom
sequenc
avail
although
variabl
strain
regard
suscept
viral
load
viral
load
vari
much
within
strain
balbc
wide
use
inbr
mous
strain
studi
rsv
infect
rsvinfect
balbc
mice
show
sign
clinic
ill
includ
weight
loss
ruffl
fur
ataxia
peak
day
infect
interestingli
suscept
rsv
replic
nose
lung
increas
age
predomin
histolog
find
rsvinfect
balbc
mice
peribronchiolar
perivascular
accumul
mononuclear
cell
role
cell
respons
rsv
infect
domin
focu
balbc
mous
studi
context
rsv
infect
induc
respons
domin
high
ifnlevel
lung
infect
mice
abund
ifn
produc
cell
bronchoalveolar
lavag
fluid
balf
rsvspecif
cytotox
cell
ctl
respons
mice
balbc
background
describ
excel
rsv
diseas
phenotyp
review
although
model
limit
probabl
exactli
mirror
complex
natur
infect
human
regard
attract
tool
studi
rsv
pathogenesi
evalu
novel
therapi
addit
mous
model
infect
chinchilla
infect
natur
host
studi
detail
bovin
respiratori
syncyti
viru
major
caus
respiratori
ill
calv
studi
context
clinic
sign
experiment
infect
includ
cough
lung
sound
dyspnea
fever
increas
respiratori
rate
pulmonari
resist
promin
histolog
find
includ
prolif
bronchiol
alveol
syncytia
extent
emphysema
rsv
infect
calv
might
use
evalu
vaccin
strategi
howev
anim
model
evalu
novel
therapi
list
experiment
model
also
includ
pneumonia
viru
infect
mice
pvm
although
pvm
model
respiratori
diseas
interest
show
phenotyp
natur
infect
pvm
differ
rsv
includ
g
protein
fulfil
import
function
rsv
infect
human
parainfluenza
virus
hpiv
import
caus
respiratori
diseas
infant
children
usual
caus
urti
may
accompani
otiti
media
hpiv
may
also
caus
lrti
requir
hospit
infect
second
rsv
infect
viral
caus
seriou
acut
respiratori
infect
young
children
occur
primarili
first
month
life
may
caus
sever
diseas
approxim
infant
children
infect
develop
febril
ill
one
third
infect
individu
develop
lrti
result
bronchiti
pneumonia
children
infect
age
year
croup
main
clinic
manifest
infect
parainfluenza
virus
especi
infect
may
extend
lower
respiratori
tract
result
pneumonia
mainli
caus
mild
urti
children
adult
along
rsv
hpiv
also
lead
caus
agent
seriou
acut
respiratori
infect
communityacquir
respiratori
diseas
requir
hospit
adult
proport
hospit
associ
hpiv
infect
vari
wide
hospitalbas
studi
accord
estim
account
annual
hospit
usa
hospit
hospit
parainfluenza
virus
belong
order
mononegaviral
famili
paramyxovirida
subfamili
paramyxovirina
belong
genu
respiroviru
genu
rubulaviru
virion
spheric
envelop
particl
approxim
nm
diamet
intern
helic
nucleocapsid
virion
envelop
lipid
bilay
membran
bear
spikelik
project
compos
hemagglutininneuraminidas
hn
fusion
f
protein
paramyxovirus
hpiv
contain
neg
strand
nonseg
rna
genom
encod
two
envelop
glycoprotein
hn
f
protein
matrix
protein
nucleocapsid
protein
np
sever
nonstructur
protein
includ
polymeraseassoci
protein
pv
viral
replicas
l
review
replic
piv
similar
paramyxovirus
rna
genom
serv
templat
transcript
mrna
bind
hn
glycoprotein
cell
receptor
initi
infect
addit
function
hn
thought
enhanc
fusion
activ
f
follow
viru
attach
host
cell
mediat
fusion
viru
subsequ
penetr
f
also
mediat
fusion
infect
uninfect
cell
allow
viru
spread
f
synthes
inact
precursor
f
posttransl
cleav
host
cell
proteas
yield
two
subunit
f
f
remain
link
disulfid
bond
mucou
membran
upper
respiratori
tract
common
site
infect
promin
clinic
symptom
hpiv
infect
character
rhiniti
pharyng
bronchiti
incub
period
day
cough
hoars
fever
last
approxim
day
frequent
involv
trachea
result
croup
extens
lower
respiratori
tract
may
lead
pneumonia
sever
diseas
character
bronchopneumonia
bronchiol
observ
infect
specif
viru
host
properti
determin
sever
hpivrel
diseas
yet
understood
infect
piv
induc
immun
respons
hn
f
neutral
antibodi
piv
correl
partial
resist
infect
clinic
symptom
usual
prevent
reinfect
secretori
iga
neutral
antibodi
import
adult
children
mention
hpiv
import
caus
respiratori
tract
diseas
infant
children
epidem
usual
occur
earli
spring
virus
persist
long
time
environ
season
peak
infect
reflect
season
croup
highest
autumn
usa
croup
winter
month
like
caus
virus
influenza
viru
rsv
diagnosi
piv
infect
mainli
clinic
molecular
diagnost
procedur
usual
perform
specif
antivir
treatment
piv
avail
therapeut
intervent
mainli
target
symptom
croup
earli
treatment
reduc
sever
symptom
rate
patient
return
health
care
practition
addit
medic
attent
visit
emerg
depart
admiss
hospit
effect
vaccin
current
avail
attenu
strain
studi
virosom
formul
vaccin
current
develop
nation
institut
allergi
infecti
diseas
niaid
studi
safeti
immunogen
recombin
liveattenu
chimer
bovinehuman
parainfluenza
type
viru
rb
vaccin
phase
studi
test
vaccin
deliv
nose
drop
adult
year
age
children
month
age
infant
children
month
age
hpiv
vaccin
also
develop
compani
adenovirus
caus
infect
respiratori
gastrointestin
tract
kidney
eye
organ
latter
mostli
consequ
immunosuppress
known
frequent
caus
respiratori
infect
among
peopl
institut
environ
outbreak
among
children
report
board
school
summer
camp
outbreak
also
report
militari
camp
infect
adenoviru
result
infect
upper
respiratori
tract
addit
adenoviru
infect
may
result
conjunct
tonsil
ear
infect
croup
adenovirus
respons
approxim
acut
respiratori
infect
children
age
adenovirus
belong
famili
adenovirida
genu
mastadenoviru
speci
includ
human
adenoviru
af
immunolog
distinct
human
adenoviru
serotyp
common
human
adenovir
pathogen
belong
c
adenovirus
mainli
infect
upper
respiratori
tract
virion
envelop
consist
capsid
core
protein
associ
icosahedr
capsid
diamet
nm
capsid
consist
capsom
surfac
structur
reveal
regular
pattern
distinct
featur
surfac
project
often
lost
prepar
distinct
filament
protrud
vertic
penton
genom
segment
contain
singl
molecul
linear
doublestrand
dna
termin
redund
sequenc
invert
termin
repetit
itr
complet
genom
mastadenovirus
approxim
kpb
long
guanin
cytosin
content
genom
termin
protein
coval
link
dna
strand
viral
genom
encod
structur
protein
nonstructur
protein
virion
consist
protein
locat
capsid
fiber
core
capsid
compris
seven
polypeptid
polypeptid
ii
basi
hexon
three
tightli
associ
protein
polypeptid
vi
viii
ix
associ
hexon
polypeptid
vi
viii
serv
bridg
capsid
core
five
polypeptid
iii
copi
basi
penton
polypeptid
iv
form
trimer
fiber
knob
domain
serv
viral
receptor
target
host
cell
cell
receptor
receptor
coxsacki
b
viru
adenoviru
car
adenovirus
c
e
f
adenovirus
b
except
serotyp
core
consist
four
protein
v
vii
mu
termin
protein
coval
link
end
dna
dna
review
replic
cycl
adenovirus
divid
two
phase
earli
phase
includ
adsorpt
viru
host
cell
penetr
transcript
translat
earli
gene
earli
gene
product
mediat
gene
express
dna
replic
block
apoptosi
promot
cell
cycl
progress
addit
possess
potent
immunomodulatori
function
review
viral
gene
product
briefli
mention
nucleu
activ
express
number
gene
interact
cellular
transcript
factor
cellular
regulatori
protein
postul
play
role
pathogenesi
chronic
obstruct
pulmonari
diseas
copd
human
adenoviru
af
caus
human
infect
rang
respiratori
diseas
conjunct
b
gastroenter
f
serotyp
common
clinic
pictur
adenoviru
infect
respiratori
tract
mild
selflimit
upper
respiratori
diseas
nasal
congest
coryza
cough
patient
develop
exsud
tonsil
clinic
indistinguish
streptococcu
tonsil
infect
commonli
caus
serotyp
c
adenovirus
serotyp
b
adenoviru
respiratori
symptom
may
accompani
system
manifest
includ
gener
malais
chill
fever
headach
howev
adenovirus
may
infect
alveolar
bronchiolar
epitheli
cell
caus
pneumonia
bronchiol
bronchiol
obliteran
adenovirus
account
approxim
pneumonia
children
contrast
mani
respiratori
virus
persist
latent
infect
describ
particularli
lymphocyt
adenovir
dna
may
persist
nuclei
infect
cell
even
integr
host
dna
adenovir
protein
postul
play
role
pathogenesi
copd
adenovir
dna
found
lung
copd
patient
express
correl
diseas
sever
respons
inflammatori
stimuli
increas
express
along
nuclear
factorb
nfb
activ
lung
epitheli
cell
review
factor
support
emphysema
upregul
transform
growth
bronchiolar
epitheli
cell
support
role
airway
remodel
summari
adenovirus
pathogen
frequent
caus
mild
sever
acut
infect
respiratori
tract
import
adenoviru
infect
howev
goe
beyond
acut
airway
diseas
adenovirus
nonenvelop
pathogen
thu
stabl
chemic
physic
agent
advers
ph
condit
believ
respiratori
adenovirus
mainli
spread
via
aerosol
howev
rout
fecal
waterborn
also
frequent
lead
infect
antibodi
one
adenovirus
found
approxim
infant
nearli
adult
sinc
mani
differ
type
adenoviru
repeat
adenovir
infect
occur
although
adenoviru
infect
occur
time
year
respiratori
tract
diseas
caus
adenoviru
common
late
winter
spring
earli
summer
virolog
diagnosi
perform
use
varieti
molecular
immunolog
approach
howev
import
context
sever
epidem
diseas
develop
effort
vaccin
discontinu
antivir
therapi
import
infect
immunocompromis
patient
patient
cidofovir
shown
promis
human
metapneumoviru
hmpv
identifi
today
consid
major
caus
acut
respiratori
infect
worldwid
especi
children
virtual
children
experienc
infect
hmpv
age
year
review
hmpv
member
order
mononegaviral
famili
paramyxovirida
subfamili
pneumovirina
rsv
genu
metapneumoviru
two
major
group
least
four
subgroup
hmpv
hmpv
particl
envelop
pleomorph
filament
spheric
mean
diamet
approxim
nm
genom
consist
singlestrand
neg
rna
approxim
kb
contain
eight
gene
order
code
nucleoprotein
n
phosphoprotein
p
matrix
protein
fusion
protein
f
transcript
elong
factor
protein
regul
rna
synthesi
small
hydrophob
protein
sh
attach
protein
g
polymeras
subunit
l
probabl
addit
protein
f
protein
major
immunogen
viral
protein
replic
gener
compar
member
mononegaviral
viru
infect
occur
primarili
winter
month
earli
spring
manifest
upper
lower
respiratori
tract
diseas
sever
hmpv
infect
viru
detect
alveolar
airway
epitheli
cell
also
report
studi
viru
caus
acut
organ
lung
injuri
tissu
damag
observ
paramyxoviru
infect
induct
smudg
cell
format
clinic
symptom
associ
hmpv
infect
indistinguish
rsv
infect
rang
common
cold
pneumonia
otiti
media
observ
infect
individu
review
respiratori
virus
hmpv
may
caus
exacerb
underli
chronic
diseas
like
asthma
congest
heart
diseas
chronic
obstruct
pulmonari
diseas
import
coinfect
rsv
influenza
virus
clear
review
mani
respiratori
virus
seriou
diseas
caus
hmpv
observ
among
immunosuppress
patient
result
recent
retrospect
studi
suggest
hmpv
infect
may
import
caus
idiopath
pneumonia
syndrom
stem
cell
transplant
hmpv
thought
second
third
caus
sever
acut
respiratori
tract
infect
children
rank
behind
rsv
influenza
viru
infect
occur
earli
life
children
experienc
hmpv
infect
age
year
reinfect
occur
frequent
incid
hospit
children
acut
respiratori
tract
infect
rang
incid
patient
consult
outpati
clinic
review
rout
transmiss
believ
similar
rsv
respiratori
droplet
handto
mouth
handto
eye
contact
diagnosi
hmpv
infect
mainli
clinic
molecular
diagnost
procedur
usual
perform
routin
possibl
use
standard
technolog
like
rtpcr
immunolog
techniqu
specif
antivir
treatment
avail
howev
ribavirin
shown
promis
monoclon
antibodi
develop
could
potenti
use
prevent
hmpv
infect
sever
vaccin
develop
still
earli
stage
human
bocaviru
hbov
parvoviru
detect
children
lrti
use
random
amplif
method
hbov
infect
predominantli
associ
respiratori
andor
gastrointestin
symptom
children
around
year
age
seropreval
reach
adult
howev
role
hbov
pathogenesi
human
respiratori
disord
yet
fulli
understood
hbov
infect
frequent
accompani
coinfect
viral
bacteri
pathogen
hbov
classifi
parvovirida
famili
subfamili
parvovirina
genu
bocaviru
parvovirus
hbov
virion
icosahedr
nonenvelop
particl
diamet
nm
hbov
genom
linear
singlestrand
dna
encompass
approxim
kb
organ
like
parvovirus
conserv
gene
encod
two
nonstructur
protein
locat
region
gene
two
structur
protein
locat
region
genom
structur
protein
ident
sequenc
differ
ntermin
extens
present
uniqu
region
possess
phospholipas
activ
function
two
nonstructur
protein
hbov
known
howev
regulatori
function
parvovirus
describ
hbov
detect
children
respiratori
diseas
rang
clinic
manifest
broad
diseas
upper
rhiniti
cough
lower
respiratori
tract
includ
pneumonia
bronchiol
wheez
even
gastrointestin
diseas
describ
review
symptom
includ
fever
rash
howev
hbov
infect
link
frequent
coinfect
viral
bacteri
pathogen
approxim
hbov
dnaposit
individu
make
rather
difficult
distinguish
symptom
caus
hbov
pathogen
role
vertic
transmiss
seen
parvovirus
known
antibodi
viral
structur
protein
detect
approxim
children
older
year
adult
addit
subclass
antibodi
hbov
particl
vlp
detect
approxim
sampl
obtain
healthi
adult
blood
donor
author
found
igm
antibodi
sera
hbov
dnaposit
children
sampl
dnaneg
children
cellular
immun
also
play
role
hbov
infect
frequent
helper
cell
reaction
observ
hbov
vlp
mani
epidemiolog
aspect
discuss
howev
noteworthi
major
analys
perform
symptomat
individu
data
asymptomat
healthi
children
adult
would
add
understand
hbov
epidemiolog
diagnosi
hbov
infect
mainli
done
pcr
amplif
viral
dna
detect
antihbov
antibodi
elisa
present
specif
treatment
hbov
infect
avail
coronavirus
known
caus
varieti
diseas
anim
human
coronavirus
mainli
associ
respiratori
disord
may
caus
enter
infect
human
coronavirus
identifi
coronaviru
caus
sever
acut
human
respiratori
syndrom
sar
sarscov
first
describ
two
addit
human
coronavirus
link
respiratori
disord
identifi
recent
econom
import
coronavirus
veterinari
medicin
instanc
swine
develop
vaccin
advanc
veterinari
medicin
human
medicin
howev
appear
sar
coronaviru
human
coronavirus
gain
greater
share
interest
coronavirus
belong
order
nidoviral
famili
coronavirida
genu
coronaviru
addit
five
human
coronavirus
hcovnl
sarscov
specif
human
enter
coronaviru
report
coronavirus
assign
three
group
base
antigen
relationship
speci
differ
group
review
includ
group
group
sarscov
repres
earli
split
group
coronavirus
envelop
virus
approxim
nm
diamet
larg
nm
clubshap
surfac
project
spike
protein
structur
function
protein
review
elsewher
apart
coronavirus
smaller
membran
protein
review
addit
coronavirus
third
envelop
protein
small
nonglycosyl
e
protein
e
found
essenti
viru
particl
format
review
group
coronavirus
also
hemagglutinin
esteras
protein
form
layer
approxim
nm
neuramin
acetylesteras
hydrolys
sialic
acid
erythrocyt
thu
potenti
destroy
receptor
anoth
coronaviru
protein
n
close
link
rna
genom
form
ribonucleoprotein
rnp
n
may
function
role
replic
transcript
phosphoryl
review
coronavirus
positivesens
singlestrand
rna
genom
kb
genom
gener
organ
follow
manner
genestructur
protein
utr
untransl
region
nucleotid
structur
protein
encod
follow
order
group
coronavirus
e
n
infect
initi
bind
protein
cell
receptor
human
aminopeptidas
n
apn
metalloproteinas
locat
surfac
epitheli
cell
identifi
cell
receptor
metallopeptidas
angiotensin
convert
enzym
ace
may
cell
receptor
sarscov
bind
protein
cell
receptor
induc
conform
chang
trigger
fusogen
activ
coronaviru
genom
releas
cytoplasm
fusion
envelop
cell
membran
mediat
region
protein
replic
occur
within
cytoplasm
earli
infect
genom
rna
releas
act
mrna
translat
first
gene
polymeras
mrna
gene
gener
subsequ
gener
coronavirus
sever
cotermin
subgenom
mrna
socal
nest
set
uniqu
part
mrna
within
next
smaller
mrna
translat
replic
cycl
end
gene
sequenc
common
gene
socal
transcriptionassoci
sequenc
name
impli
associ
discontinu
transcript
process
review
variou
mechan
propos
product
subgenom
mrna
review
elsewher
human
coronavirus
gener
thought
common
cold
agent
role
confirm
healthi
volunt
infect
develop
classic
common
cold
symptom
wherea
infect
result
mild
diseas
even
asymptomat
addit
factor
like
immunosuppress
coinfect
might
caus
sever
diseas
even
pneumonia
clear
whether
infect
lower
respiratori
tract
otherwis
healthi
peopl
urti
observ
popul
suggest
lower
respiratori
tract
suscept
hcov
infect
children
studi
perform
healthi
adult
less
inform
suscept
vulner
popul
children
elderli
howev
nucleic
acid
frequent
detect
children
respiratori
tract
diseas
use
rtpcr
wherea
otherwis
healthi
control
group
asymptomat
bone
marrow
recipi
one
sampl
test
posit
p
find
suggest
coronavirus
caus
upper
lower
respiratori
tract
diseas
children
sever
adult
suggest
wheez
episod
asthmat
children
may
due
coronaviru
infect
detect
young
hospit
children
sever
lrti
viru
also
detect
elderli
patient
fatal
respiratori
diseas
risk
develop
croup
time
higher
children
shown
posit
test
neg
first
detect
elderli
children
underli
diseas
symptom
includ
rhinorrhea
fever
cough
wheez
well
bronchiol
pneumonia
might
also
caus
gastrointestin
diseas
hcov
infect
result
antibodi
titer
serum
secretori
antibodi
detect
respiratori
enter
tract
milk
colostrum
infect
hcov
peak
winter
season
estim
approxim
common
cold
case
caus
coronavirus
outbreak
differ
human
coronavirus
found
altern
everi
year
although
earli
studi
demonstr
antibodi
coronavirus
frequent
present
adult
new
studi
suggest
differ
respect
hcov
speci
hofmann
et
al
demonstr
infect
occur
less
frequent
measur
specif
antibodi
neutral
either
addit
codetect
coronavirus
virus
common
coronavirus
human
coronavirus
speci
specif
howev
sar
coronaviru
probabl
origin
anim
reservoir
presum
bat
transmit
human
civet
cat
transmiss
human
coronavirus
human
human
occur
via
secret
like
aerosol
respiratori
droplet
case
enter
infect
fece
adult
acut
symptomat
inappar
infect
transmit
viru
infant
develop
clinic
diseas
diagnosi
hcov
infect
clinic
etiolog
diagnosi
howev
perform
use
molecular
immunolog
techniqu
vaccin
coronaviru
diseas
develop
domest
anim
econom
import
human
recent
antivir
strategi
coronaviru
infect
review
elsewher
strategi
explor
small
interf
rna
block
viral
entri
eg
use
carbohydratebind
agent
neutral
antibodi
addit
viral
enzym
like
proteas
helicas
studi
potenti
target
novel
antivir
review
accord
estim
burden
influenza
usa
current
estim
million
case
per
year
lead
hospit
death
per
year
number
extrapol
rest
world
influenza
viru
would
infect
world
popul
caus
million
case
sever
diseas
approxim
million
death
per
year
although
number
high
would
character
interpandem
influenza
epidem
outbreak
influenza
follow
season
pattern
differ
accord
region
world
temper
climat
zone
season
epidem
typic
begin
late
fall
peak
late
winter
season
pattern
less
pronounc
tropic
zone
review
focu
book
common
cold
detail
influenza
influenza
virus
read
standard
literatur
recommend
influenza
virus
member
orthomyxovirida
genu
influenzaviru
includ
influenza
viru
type
b
c
virus
envelop
pleomorph
particl
size
rang
nm
genom
organ
eight
influenza
viru
b
seven
influenza
viru
c
negativesens
singlestrand
rna
segment
spike
consist
hemagglutinin
ha
neuraminidas
na
nomenclatur
human
influenza
viru
includ
type
geograph
locat
first
isol
isol
number
year
isol
addit
subtyp
influenza
describ
ha
na
design
date
ha
na
type
describ
viral
envelop
also
associ
matrix
protein
infect
form
tetramer
ion
channel
sever
polymeras
protein
pa
form
togeth
nucleoprotein
np
rna
ribonucleoprotein
rnp
complex
review
influenza
virus
transmit
via
respiratori
rout
bind
cell
receptor
consist
oligosaccharid
present
surfac
respiratori
epitheli
cell
sialic
linkag
sa
associ
bind
human
influenza
viru
ha
present
human
respiratori
tract
review
bind
viru
enter
host
cell
endocytosi
step
includ
fusion
viru
endosom
releas
rnp
nucleu
ion
channel
form
viral
rna
templat
complementari
rna
mrna
nonstructur
well
play
role
nuclear
export
novel
rna
assembl
occur
apic
surfac
cell
bud
occur
novel
viru
releas
review
influenza
virus
transmit
via
respiratori
rout
host
specif
larg
determin
avail
host
cell
receptor
surfac
epitheli
cell
usual
influenza
human
urti
character
cough
headach
malais
fever
howev
complic
frequent
enceph
rey
syndrom
myeliti
well
muscular
manifest
infect
includ
myocard
dissemin
intravascular
coagul
toxic
septic
shock
may
occur
major
airway
congest
inflamm
necrosi
found
histopatholog
examin
although
much
progress
understand
pathogenesi
human
influenza
made
past
decad
molecular
mechan
respons
virul
particular
strain
influenza
viru
yet
understood
influenza
viru
infect
human
well
waterfowl
chicken
swine
hors
speci
influenza
b
viru
hand
restrict
host
rang
circul
predominantli
human
howev
influenza
b
viru
recent
isol
seal
differ
type
ha
mediat
speciesspecif
bind
viru
would
beyond
scope
book
common
cold
review
recent
literatur
publish
regard
epidemiolog
influenza
virus
howev
one
import
aspect
mention
influenza
viru
chang
viru
repetit
occurr
yearli
epidem
support
antigen
drift
accumul
point
mutat
viral
receptor
ha
na
drift
attribut
low
fidel
viral
rna
polymeras
new
variant
infect
popul
without
preexist
immun
review
second
process
contribut
emerg
new
influenza
variant
call
antigen
shift
antigen
shift
may
occur
coinfect
influenza
virus
coinfect
may
lead
viral
reassort
exchang
genom
segment
differ
viru
strain
process
lead
new
viru
strain
abl
effect
spread
individu
individu
worldwid
outbreak
pandem
may
occur
sever
pandem
past
centuri
includ
socal
spanish
flu
infect
half
world
popul
time
kill
approxim
million
peopl
current
pandem
concern
focus
highli
pathogen
variant
strain
epidemiolog
influenza
comprehens
review
influenza
typic
diagnos
clinic
laboratori
diagnosi
establish
organ
accord
standard
procedur
part
nation
global
pandem
plan
sever
effect
vaccin
exist
today
review
prepandem
vaccin
licens
recent
